Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, and respiratory syncytial virus (RSV) are significant global health threats. The need for low-cost, easily synthesized oral drugs for rapid deployment during outbreaks is crucial. Broad-spectrum therapeutics, or pan-antivirals,...

Повний опис

Бібліографічні деталі

Автори:	Harry Ridgway, Vasso Apostolopoulos, Graham J. Moore, Laura Kate Gadanec, Anthony Zulli, Jordan Swiderski, Sotirios Tsiodras, Konstantinos Kelaidonis, Christos T. Chasapis, John M. Matsoukas
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2024-11-01
Серія:	Viruses
Предмети:	arginine blockers bisartans benzimidazole sartans coronavirus 2019 influenza pan-antivirals
Онлайн доступ:	https://www.mdpi.com/1999-4915/16/11/1776
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!